1 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow ABI-1179: new trials by email Literature Review of ABI-1179 trials Research Report on ABI-1179
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Assess the Safety, Pharmacokinetics, and Tolerability of ABI-1179 in Healthy Subjects and in Subjects Seropositive for HSV-2 With Recurrent Genital Herpes ABI-1179, ABI-1179 Placebo - Recurrent Genital Herpes Simplex Type 2 | Phase 1 | Completed | Assembly Biosciences | 103 | 2024-12-08 | 2026-03-23 |
Herpes Genitalis (1)
Australia (1) · New Zealand (1) · United States (1)